These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 15233733

  • 1. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D.
    Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma.
    Thirdborough SM, Radcliffe JN, Friedmann PS, Stevenson FK.
    Cancer Res; 2002 Mar 15; 62(6):1757-60. PubMed ID: 11912151
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma.
    King CA, Spellerberg MB, Zhu D, Rice J, Sahota SS, Thompsett AR, Hamblin TJ, Radl J, Stevenson FK.
    Nat Med; 1998 Nov 15; 4(11):1281-6. PubMed ID: 9809552
    [Abstract] [Full Text] [Related]

  • 5. Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies.
    Savelyeva N, Munday R, Spellerberg MB, Lomonossoff GP, Stevenson FK.
    Nat Biotechnol; 2001 Aug 15; 19(8):760-4. PubMed ID: 11479570
    [Abstract] [Full Text] [Related]

  • 6. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 15; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N, King CA, Vitetta ES, Stevenson FK.
    Proc Natl Acad Sci U S A; 2005 Aug 02; 102(31):10987-92. PubMed ID: 16037207
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB, Zhu D, Thompsett A, King CA, Hamblin TJ, Stevenson FK.
    J Immunol; 1997 Aug 15; 159(4):1885-92. PubMed ID: 9257853
    [Abstract] [Full Text] [Related]

  • 9. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM.
    Cancer Res; 2007 Feb 01; 67(3):1344-51. PubMed ID: 17283172
    [Abstract] [Full Text] [Related]

  • 10. DNA vaccines against cancer come of age.
    Stevenson FK, Ottensmeier CH, Rice J.
    Curr Opin Immunol; 2010 Apr 01; 22(2):264-70. PubMed ID: 20172703
    [Abstract] [Full Text] [Related]

  • 11. DNA gene fusion vaccines against cancer.
    Zhu D, Stevenson FK.
    Curr Opin Mol Ther; 2002 Feb 01; 4(1):41-8. PubMed ID: 11883694
    [Abstract] [Full Text] [Related]

  • 12. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.
    Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK.
    Cancer Res; 2006 May 15; 66(10):5436-42. PubMed ID: 16707472
    [Abstract] [Full Text] [Related]

  • 13. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E.
    Clin Cancer Res; 2005 Aug 01; 11(15):5566-71. PubMed ID: 16061874
    [Abstract] [Full Text] [Related]

  • 14. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H, Zhou C, Wang D, Ma W, Liang X, Lin C, Zhang Y, Zhang S.
    Immunol Lett; 2005 Jun 15; 99(1):85-93. PubMed ID: 15894116
    [Abstract] [Full Text] [Related]

  • 15. Genetically modified tumour vaccines--where we are today.
    Nawrocki S, Mackiewicz A.
    Cancer Treat Rev; 1999 Feb 15; 25(1):29-46. PubMed ID: 10212588
    [Abstract] [Full Text] [Related]

  • 16. DNA vaccination against tumors.
    Prud'homme GJ.
    J Gene Med; 2005 Jan 15; 7(1):3-17. PubMed ID: 15538731
    [Abstract] [Full Text] [Related]

  • 17. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M, Leder C, Pisa P.
    Expert Rev Vaccines; 2005 Jun 15; 4(3):315-27. PubMed ID: 16026247
    [Abstract] [Full Text] [Related]

  • 18. DNA fusion vaccines against B-cell tumors.
    Zhu D, Rice J, Savelyeva N, Stevenson FK.
    Trends Mol Med; 2001 Dec 15; 7(12):566-72. PubMed ID: 11733220
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 20. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
    Kim JH, Majumder N, Lin H, Chen J, Falo LD, You Z.
    Mol Ther; 2005 Jun 15; 11(6):941-9. PubMed ID: 15922965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.